Trial Profile
Prospective study investigating the correlation between protease inhibitor treatment and genetic variation in HIV-1 patients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 26 Dec 2015
Price :
$35
*
At a glance
- Drugs Lopinavir/ritonavir (Primary)
- Indications HIV-1 infections
- Focus Therapeutic Use
- 26 Dec 2015 New trial record